Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov;71(6):461-465.
doi: 10.3322/caac.21698. Epub 2021 Sep 7.

Locally advanced lung cancer

Arafat H Tfayli  1 , Pierre M Sfeir  2 , Bassem Y Youssef  3 , Fadlo R Khuri  4
Affiliations
Free article
Case Reports

Locally advanced lung cancer

Arafat H Tfayli et al. CA Cancer J Clin. 2021 Nov.
Free article
No abstract available

PubMed Disclaimer

References

    1. Pless M, Stupp R, Ris HB, et al. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet. 2015;386:1049-1056.
    1. Forde PM, Chaft JE, Smith KN, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018;378:1976-1986.
    1. Kwiatkowski DJ, Rusch VW, Chaft JE, et al. Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): interim analysis and biomarker data from a multicenter study (LCMC3) [abstract]. J Clin Oncol. 2019;37(15 suppl):8503.
    1. Cascone T, William WN, Weissferdt A, et al. Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): clinical and correlative results from the NeoSTAR study [abstract]. J Clin Oncol. 2019;37(15 suppl):8504.
    1. Tfayli A, Al Assaad M, Fakhri G, et al. Neoadjuvant chemotherapy and avelumab in early stage resectable non-small cell lung cancer. Cancer Med. 2020;9:8406-8411.

Publication types

MeSH terms

Substances

LinkOut - more resources